Affiliation:
1. Medical University of South Carolina
2. Mount Sinai Medical Center: Mount Sinai Health System
3. UNC-Chapel Hill: The University of North Carolina at Chapel Hill
4. Rush University
5. UCLA Anderson School of Management: University of California Los Angeles Anderson School of Management
6. Saint Louis University
Abstract
Abstract
Background: There is a lack of registry studies about Transradial access (TRA) outcomes. This prospective registry focused on evaluating the TRA and procedure outcomes of visceral embolizations performed via TRA with 30-day follow-up.
Material & Methods: Prospective, multicenter registry included uterine fibroids (UFE), prostate artery (PAE), liver tumors (LT), and other hypervascular tumors (OHT) embolization performed in six US hospitals. Between February 2020 and January 2022,99 patients underwent one RAVI; 70 had UFE (70.7%), 16 PAE (16.2%), 7 LT (7.1%), and 6 OHT (6.1%). The mean age was 50.1 (±11.1) years and 74/99 (74.7%) were females. The primary safety endpoints included hand ischemia, stroke, and death. Procedural success was defined as the completion of the intended procedure using RA. Technical success was defined as the successful delivery of HydroPearl™ microspheres and complete embolization of the target vessel.
Results: Procedural and technical successes were 100% and 97%, respectfully. There was no stroke, hand ischemia, radial-to-femoral conversion, access-related serious adverse events, or clinically evident radial artery occlusion at 30 days. There were two deaths: one respiratory failure and one progression of liver disease. Minor RA-related adverse event included arterial spasm, hematoma, and post-procedure discomfort.
Conclusion: This prospective, multicenter, open-label registry confirmed the high safety profile and effectiveness of radial access in UFE, PAE, LT, and OHT embolization procedures without stroke, hand ischemia or access-related serious adverse events at 30 days follow-up.
Publisher
Research Square Platform LLC
Reference20 articles.
1. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC);Roffi M;Eur Heart J,2016
2. Members WC, Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, Bittl JA, Cohen MG, DiMaio JM, Don CW, Fremes SE, Gaudino MF, Goldberger ZD, Grant MC, Jaswal JB, Kurlansky PA, Mehran R, Metkus TS Jr, Nnacheta LC, Rao SV, Sellke FW, Sharma G, Yong CM, Zwischenberger BA (2021) ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2022; 79(2):e21-e129. doi: 10.1016/j.jacc.2021.09.006. Epub 2021 Dec 9. Erratum in: J Am Coll Cardiol 2022; 79(15):1547. PMID: 34895950
3. Transradial Approach for Noncoronary Interventions: A Single-Center Review of Safety and Feasibility in the First 1,500 Cases;Posham R;J Vasc Interv Radiol,2016
4. Hepatic radioembolization from transradial access: initial experience and comparison to transfemoral access;Kis B;Diagn Interv Radiol,2016
5. Bishay VL, Biederman DM, Ward TJ, van der Bom IM, Patel RS, Kim E, Nowakowski FS, Lookstein RA, Fischman AM (2016) ; 207(5):1112–1121. 10.2214/AJR.15.15615. PMID: 27767350